Nasdaq · CIK 0000926282
ADTN ADTRAN Holdings, Inc.
Insider trading from SEC Form 4. Last filing May 22, 2026. Close $7.46 on Oct 9, 2026, +10% from the 52-week low and -62% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
ADTNOct 9, 2026 · close 7.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ADTRAN Holdings, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | James Denson Wilson Jr Chief Revenue Officer sell | $137k 9,332 shares | -6% | +100% from low-22% from high | |
| 33Weak | Christoph Glingener Chief Technology Officer sell | $2.2M 148,392 shares | -169% | +101% from low-21% from high | |
| 46Moderate | Hourigan Rice Jacqueline director sell | $148k 14,406 shares | -51% | +43% from low-4% from high | |
| 46Moderate | Nikos Theodosopoulos director buy | $100k 12,859 shares | +33% | - | |
| 50Moderate | Timothy P Santo SVP of Finance; CFO buy | $49k 6,150 shares | +30% | - | |
| 54Moderate | Thomas R Stanton Chairman & CEO buy | $300k 40,928 shares | +4% | - |
Transactions
The last 71 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | James Denson Wilson Jr Chief Revenue Officer | SOpen-market sale Common Stock | -9,332 | $14.72 | $137k | 143,277 | May 22, 2026 |
| May 20, 2026 | James Denson Wilson Jr Chief Revenue Officer | GGift Common Stock | -10,469 | $0.00 | $0 | 132,808 | May 22, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Common Stock10b5-1 | +41,220 | $7.01 | $289k | 87,865 | May 11, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | SOpen-market sale Common Stock10b5-1 | -41,220 | $14.73 | $607k | 46,645 | May 11, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Common Stock10b5-1 | +84,895 | $12.17 | $1.0M | 131,540 | May 11, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | SOpen-market sale Common Stock10b5-1 | -84,895 | $15.06 | $1.3M | 46,645 | May 11, 2026 |
| May 8, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Common Stock10b5-1 | +22,277 | $12.17 | $271k | 68,922 | May 11, 2026 |
| May 8, 2026 | Christoph Glingener Chief Technology Officer | SOpen-market sale Common Stock10b5-1 | -22,277 | $15.00 | $334k | 46,645 | May 11, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Stock Optionderivative10b5-1 | -41,220 | $0.00 | $0 | 0 | May 11, 2026 |
| May 7, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Stock Optionsderivative10b5-1 | -84,895 | $0.00 | $0 | 22,277 | May 11, 2026 |
| May 8, 2026 | Christoph Glingener Chief Technology Officer | MOption exercise Stock Optionderivative10b5-1 | -22,277 | $0.00 | $0 | 0 | May 11, 2026 |
| Apr 1, 2026 | Thomas R Stanton Chairman & CEO | AGrant or award Common Stock | +170,723 | $0.00 | $0 | 1,126,554 | Apr 3, 2026 |
| Apr 1, 2026 | Timothy P Santo SVP of Finance; CFO | AGrant or award Common Stock | +28,252 | $0.00 | $0 | 53,345 | Apr 3, 2026 |
| Apr 1, 2026 | James Denson Wilson Jr Chief Revenue Officer | AGrant or award Common Stock | +24,908 | $0.00 | $0 | 152,609 | Apr 3, 2026 |
| Mar 19, 2026 | Timothy P Santo SVP of Finance; CFO | FTax withholding Common Stock | -1,501 | $11.90 | $18k | 25,093 | Mar 23, 2026 |
| Jan 24, 2025 | Thomas R Stanton Chairman & CEO | AGrant or award Common Stock | +39,735 | $0.00 | $0 | 815,953 | Mar 5, 2026 |
| Mar 4, 2026 | Hourigan Rice Jacqueline director | SOpen-market sale Common Stock | -14,406 | $10.29 | $148k | 13,809 | Mar 5, 2026 |
| Jan 26, 2026 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -1,309 | $9.24 | $12k | 127,701 | Jan 30, 2026 |
| Jan 26, 2026 | Thomas R Stanton Chairman & CEO | AGrant or award Common Stock | +27,973 | $0.00 | $0 | 967,878 | Jan 28, 2026 |
| Jan 26, 2026 | James Denson Wilson Jr Chief Revenue Officer | AGrant or award Common Stock | +3,777 | $0.00 | $0 | 129,010 | Jan 28, 2026 |
| Jan 26, 2026 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -12,407 | $9.24 | $115k | 955,471 | Jan 28, 2026 |
| Jan 26, 2026 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -1,087 | $9.24 | $10k | 127,923 | Jan 28, 2026 |
| Jan 24, 2026 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -17,535 | $9.55 | $167k | 954,314 | Jan 27, 2026 |
| Jan 24, 2026 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -1,227 | $9.55 | $12k | 126,231 | Jan 27, 2026 |
| Jan 26, 2026 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -998 | $9.73 | $9,711 | 125,233 | Jan 27, 2026 |
| Jan 26, 2026 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -14,409 | $9.73 | $140k | 939,905 | Jan 27, 2026 |
| Jan 20, 2026 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -765 | $9.24 | $7,069 | 127,458 | Jan 22, 2026 |
| Jan 20, 2026 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -10,247 | $9.24 | $95k | 971,849 | Jan 22, 2026 |
| Dec 31, 2025 | Hourigan Rice Jacqueline director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 28,215 | Jan 5, 2026 |
| Dec 31, 2025 | H Fenwick Huss director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 107,600 | Jan 5, 2026 |
| Dec 31, 2025 | Balan Nair director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 125,373 | Jan 5, 2026 |
| Dec 31, 2025 | Gregory James McCray director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 72,893 | Jan 5, 2026 |
| Dec 31, 2025 | Nikos Theodosopoulos director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 65,963 | Jan 5, 2026 |
| Dec 31, 2025 | Kathryn A Walker director | AGrant or award Common Stock | +13,809 | $0.00 | $0 | 98,663 | Jan 5, 2026 |
| Nov 28, 2025 | Timothy P Santo SVP of Finance; CFO | POpen-market purchase Common Stock | +6,150 | $8.02 | $49k | 26,594 | Dec 1, 2025 |
| Nov 26, 2025 | Nikos Theodosopoulos director | POpen-market purchase Common Stock | +12,859 | $7.81 | $100k | 52,154 | Dec 1, 2025 |
| Nov 24, 2025 | Thomas R Stanton Chairman & CEO | POpen-market purchase Common Stock | +40,928 | $7.33 | $300k | 982,096 | Nov 25, 2025 |
| Nov 17, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -3,355 | $7.33 | $25k | 941,168 | Nov 19, 2025 |
| Nov 17, 2025 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -468 | $7.33 | $3,430 | 128,223 | Nov 19, 2025 |
| Jul 13, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -5,663 | $9.20 | $52k | 944,523 | Jul 15, 2025 |
| Apr 13, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -5,408 | $7.62 | $41k | 950,186 | Apr 15, 2025 |
| Mar 19, 2025 | Timothy P Santo SVP of Finance; CFO | AGrant or award Common Stock | +20,444 | $0.00 | $0 | 20,444 | Mar 20, 2025 |
| Jan 24, 2025 | Thomas R Stanton Chairman & CEO | AGrant or award Common Stock | +39,375 | $0.00 | $0 | 815,593 | Jan 28, 2025 |
| Jan 24, 2025 | James Denson Wilson Jr Chief Revenue Officer | AGrant or award Common Stock | +16,096 | $0.00 | $0 | 119,581 | Jan 28, 2025 |
| Jan 24, 2025 | Ulrich Dopfer Chief Financial Officer | AGrant or award Common Stock | +16,291 | $0.00 | $0 | 37,591 | Jan 28, 2025 |
| Jan 24, 2025 | Christoph Glingener Chief Technology Officer | AGrant or award Common Stock | +13,907 | $0.00 | $0 | 32,775 | Jan 28, 2025 |
| Jan 24, 2025 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -4,208 | $10.31 | $43k | 115,373 | Jan 28, 2025 |
| Jan 24, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -10,307 | $10.31 | $106k | 805,286 | Jan 28, 2025 |
| Jan 24, 2025 | Ulrich Dopfer Chief Financial Officer | FTax withholding Common Stock | -4,613 | $10.31 | $48k | 32,978 | Jan 28, 2025 |
| Jan 24, 2025 | Christoph Glingener Chief Technology Officer | AGrant or award Common Stock | +13,870 | $0.00 | $0 | 46,645 | Jan 28, 2025 |
| Jan 24, 2025 | James Denson Wilson Jr Chief Revenue Officer | AGrant or award Common Stock | +14,163 | $0.00 | $0 | 129,536 | Jan 28, 2025 |
| Jan 24, 2025 | Thomas R Stanton Chairman & CEO | AGrant or award Common Stock | +159,844 | $0.00 | $0 | 965,130 | Jan 28, 2025 |
| Jan 24, 2025 | Ulrich Dopfer Chief Financial Officer | AGrant or award Common Stock | +16,384 | $0.00 | $0 | 49,362 | Jan 28, 2025 |
| Jan 26, 2025 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -845 | $10.31 | $8,712 | 128,691 | Jan 28, 2025 |
| Jan 26, 2025 | Ulrich Dopfer Chief Financial Officer | FTax withholding Common Stock | -1,167 | $10.31 | $12k | 48,195 | Jan 28, 2025 |
| Jan 26, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -9,536 | $10.31 | $98k | 955,594 | Jan 28, 2025 |
| Jan 20, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -6,395 | $10.19 | $65k | 776,218 | Jan 22, 2025 |
| Jan 20, 2025 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -765 | $10.19 | $7,795 | 103,485 | Jan 22, 2025 |
| Jan 13, 2025 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -6,018 | $10.01 | $60k | 782,613 | Jan 15, 2025 |
| Dec 31, 2024 | Balan Nair director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 111,564 | Jan 3, 2025 |
| Dec 31, 2024 | Hourigan Rice Jacqueline director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 30,755 | Jan 3, 2025 |
| Dec 31, 2024 | H Fenwick Huss director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 93,791 | Jan 3, 2025 |
| Dec 31, 2024 | Kathryn A Walker director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 84,854 | Jan 3, 2025 |
| Dec 31, 2024 | Gregory James McCray director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 59,084 | Jan 3, 2025 |
| Dec 31, 2024 | Nikos Theodosopoulos director | AGrant or award Common Stock | +14,406 | $0.00 | $0 | 39,295 | Jan 3, 2025 |
| Dec 31, 2024 | Hourigan Rice Jacqueline director | GGift Common Stock | -16,349 | $0.00 | $0 | 14,406 | Jan 3, 2025 |
| Nov 16, 2024 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -5,572 | $7.75 | $43k | 805,404 | Nov 19, 2024 |
| Nov 16, 2024 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -794 | $7.75 | $6,154 | 106,590 | Nov 19, 2024 |
| Nov 17, 2024 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -16,773 | $7.75 | $130k | 788,631 | Nov 19, 2024 |
| Nov 17, 2024 | James Denson Wilson Jr Chief Revenue Officer | FTax withholding Common Stock | -2,340 | $7.75 | $18k | 104,250 | Nov 19, 2024 |
| Oct 13, 2024 | Thomas R Stanton Chairman & CEO | FTax withholding Common Stock | -3,748 | $5.91 | $22k | 810,976 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Ulrich DopferChief Financial Officer
- Christoph GlingenerChief Technology Officer
- H Fenwick Hussdirector
- Hourigan Rice Jacquelinedirector, officer
- Gregory James McCraydirector
- Balan Nairceo, president, officer, director
- Thomas R StantonChairman & CEO
- Timothy P SantoSVP of Finance; CFO
- Nikos Theodosopoulosdirector
- Kathryn A Walkerdirector
- James Denson Wilson JrChief Revenue Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.